Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 44 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Flt3 ligand expands dendritic cell numbers in normal and malignant murine prostateMoghaddami, M.; Swart, B.; Reynolds, P.; Diener, K.; Brown, M.
2012The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinomaPerez-Mancera, P.; Rust, A.; van der Weyden, L.; Kristiansen, G.; Li, A.; Sarver, A.; Silverstein, K.; Grützmann, R.; Aust, D.; Rümmele, P.; Knösel, T.; Herd, C.; Stemple, D.; Kettleborough, R.; Brosnan, J.; Li, A.; Morgan, R.; Knight, S.; Yu, J.; Stegeman, S.; et al.
2012Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculatureKazenwadel, J.; Secker, G.; Liu, Y.; Rosenfeld, J.; Wildin, R.; Cuellar-Rodriguez, J.; Hsu, A.; Dyack, S.; Fernandez, C.; Chong, C.; Babic, M.; Bardy, P.; Shimamura, A.; Zhang, M.; Walsh, T.; Holland, S.; Hickstein, D.; Horwitz, M.; Hahn, C.; Scott, H.; et al.
2010Immunomodulatory properties of stem cells from human exfoliated deciduous teethYamaza, T.; Kentaro, A.; Chen, C.; Liu, Y.; Shi, Y.; Gronthos, S.; Wang, S.; Shi, S.
2010Prox1 expression is negatively regulated by miR-181 in endothelial cellsKazenwadel, J.; Michael, M.; Harvey, N.
2018New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironmentCheung, L.C.; Tickner, J.; Hughes, A.M.; Skut, P.; Howlett, M.; Foley, B.; Oommen, J.; Wells, J.E.; He, B.; Singh, S.; Chua, G.-A.; Ford, J.; Mullighan, C.G.; Kotecha, R.S.; Kees, U.R.
2006Use of a zinc fluorophore to measure labile pools of zinc in body fluids and cell-conditioned mediaZalewski, P.; TruongTran, A.; Lincoln, S.; Ward, A.; Shankar, A.; Coyle, P.; Jayaram, L.; Copley, A.; Grosser, D.; Murgia, C.; Lang, C.; Ruffin, R.
2013Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitorsWaibel, M.; Solomon, V.; Knight, D.; Ralli, R.; Kim, S.; Banks, K.; Vidacs, E.; Virely, C.; Sia, K.; Bracken, L.; Collins-Underwood, R.; Drenberg, C.; Ramsey, L.; Meyer, S.; Takiguchi, M.; Dickins, R.; Levine, R.; Ghysdael, J.; Dawson, M.; Lock, R.; et al.
2010Dasatinib alters the metastatic phenotype of B16-OVA melanoma in vivoFraser, C.; Lousberg, E.; Guerin, L.; Hughes, T.; Brown, M.; Diener, K.; Hayball, J.
2014An unexpected role for caspase-2 in neuroblastomaDorstyn, L.; Puccini, J.; Nikolic, A.; Shalini, S.; Wilson, C.; Norris, M.; Haber, M.; Kumar, S.